Fredun Pharmaceuticals
₹812.65
-41.5 (-4.86%)
13 May, 2024 23:41 BSE: 539730
NSE: FREDUNISIN: INE194R01017
Start SIP in Fredun Pharmaceuticals
Start SIPFredun Pharmaceuticals Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Fredun Pharmaceuticals Financials
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|
Oper Rev Qtr Cr | 117 | 87 | 81 | 61 | 80 |
Operating Expenses Qtr Cr | 107 | 76 | 72 | 54 | 68 |
Operating Profit Qtr Cr | 11 | 10 | 9 | 7 | 12 |
Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 |
Interest Qtr Cr | 4 | 4 | 3 | 3 | 4 |
Tax Qtr Cr | 1 | 2 | 2 | 2 | 4 |
Net Profit Qtr Cr | 5 | 4 | 4 | 2 | 4 |
Fredun Pharmaceuticals Technicals
EMA & SMA
Current Price
₹812.65
-41.5 (-4.86%)
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹862.38
- 50 Day
- ₹840.13
- 100 Day
- ₹843.04
- 200 Day
- ₹864.27
- 20 Day
- ₹853.94
- 50 Day
- ₹816.53
- 100 Day
- ₹839.04
- 200 Day
- ₹878.75
Fredun Pharmaceuticals Resistance and Support
PIVOT
₹826.52
Resistance | |
---|---|
First Resistance | 851.03 |
Second Resistance | 889.42 |
Third Resistance | 913.93 |
RSI | 45.33 |
MFI | 71.35 |
MACD Single Line | 27.13 |
MACD | 19.96 |
Support | |
---|---|
First Resistance | 788.13 |
Second Resistance | 763.62 |
Third Resistance | 725.23 |
Fredun Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 10,571 | 694,726 | 65.72 |
Week | 20,567 | 1,420,535 | 69.07 |
1 Month | 16,041 | 1,148,570 | 71.6 |
6 Month | 9,559 | 718,421 | 75.16 |
Fredun Pharmaceuticals Result Highlights
Fredun Pharmaceuticals Synopsis
BSE-Medical-Diversified
Fredun Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 274.68 Cr. and Equity Capital is Rs. 4.53 Cr. for the Year ended 31/03/2023. Fredun Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 08/06/1987 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1987PLC043662 and registration number is 043662.Market Cap | 379 |
Sales | 347 |
Shares in Float | 0.24 |
No of funds | 1 |
Yield | 0.08 |
Book Value | 3.14 |
U/D Vol ratio | 1 |
LTDebt / Equity | 4 |
Alpha | -0.14 |
Beta | 1.27 |
Fredun Pharmaceuticals
Owner Name | Apr-24 | Mar-24 | Dec-23 | Sep-23 |
---|---|---|---|---|
Promoters | 48.92% | 49.17% | 49.16% | 49.31% |
Financial Institutions/ Banks | 1.59% | 1.6% | 1.6% | 1.6% |
Individual Investors | 43.94% | 44.02% | 43.67% | 43.48% |
Others | 5.55% | 5.21% | 5.57% | 5.61% |
Fredun Pharmaceuticals Management
Name | Designation |
---|---|
Dr.(Mrs.) Daulat N Medhora | Chairman & Jt. M. D |
Mr. Fredun Medhora | Managing Director & CFO |
Mr. Nariman Medhora | Non Executive Director |
Dr. Aspi Raimalwala | Ind. Non-Executive Director |
Dr. Rohinton Kanga | Ind. Non-Executive Director |
Fredun Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Fredun Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-05-07 | Audited Results & Final Dividend | |
2024-02-14 | Quarterly Results | |
2023-12-16 | Others | Rs.0.00 alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
2023-11-08 | Quarterly Results | |
2023-07-19 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-09-22 | FINAL | Rs.0.70 per share(7%)Final Dividend |
Fredun Pharmaceuticals FAQs
What is Share Price of Fredun Pharmaceuticals ?
Fredun Pharmaceuticals share price is ₹812 As on 13 May, 2024 | 23:27
What is the Market Cap of Fredun Pharmaceuticals ?
The Market Cap of Fredun Pharmaceuticals is ₹379 Cr As on 13 May, 2024 | 23:27
What is the P/E ratio of Fredun Pharmaceuticals ?
The P/E ratio of Fredun Pharmaceuticals is 24.3 As on 13 May, 2024 | 23:27
What is the PB ratio of Fredun Pharmaceuticals ?
The PB ratio of Fredun Pharmaceuticals is 3.1 As on 13 May, 2024 | 23:27